Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2014.03.013PMID 24768241PMCID PMC4145014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HDL cholesterol, size, particle number, and residual vascular risk after potent statin therapy: the JUPITER trial

  2013cited by this paper
• High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

  2013cited by this paper
• Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

  2013cited by this paper
• Immunology of age-related macular degeneration

  2013cited by this paper
• C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts.

  2013cited by this paper
• Insights into the Genetic Architecture of Early Stage Age-Related Macular Degeneration: A Genome-Wide Association Study Meta-Analysis

  2013cited by this paper
• A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration

  2013influential reference
• Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study.

  2013cited by this paper
• Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

  2013cited by this paper
• Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

  2012cited by this paper
• Negative results Cerebral microbleeds and age-related macular degeneration : the AGES-Reykjavik Study

  2012cited by this paper
• Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration.

  2011cited by this paper
• Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study.

  2011influential reference
• Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study.

  2011cited by this paper
• Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.

  2011cited by this paper
• Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study.

  2010cited by this paper
• Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006

  2010cited by this paper
• Five‐year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study

  2009cited by this paper
• Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study

  2008cited by this paper
• The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.

  2008cited by this paper
• Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

  2008cited by this paper
• Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study.

  2008cited by this paper
• The Los Angeles Latino Eye Study

  2008cited by this paper
• The Wellcome Trust Case Control Consortium, U.K.

  2008cited by this paper
• Retinal and Cerebral Microvascular Signs and Diabetes

  2008cited by this paper
• Cigarette smoking and age-related macular degeneration in the EUREYE Study.

  2007cited by this paper
• Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics.

  2007cited by this paper
• HTRA1 Variant Confers Similar Risks to Geographic Atrophy and Neovascular Age-related Macular Degeneration

  2007cited by this paper
• Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.

  2007cited by this paper
• Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.

  2007cited by this paper
• Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis.

  2006cited by this paper
• Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study.

  2006cited by this paper
• Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera.

  2004cited by this paper
• Cholesterol and age-related macular degeneration: is there a link?

  2004cited by this paper
• Causes and prevalence of visual impairment among adults in the United States.

  2004cited by this paper
• Antiinflammatory Properties of HDL

  2004cited by this paper
• The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.

  2003cited by this paper
• Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

  2003cited by this paper
• The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.

  2003cited by this paper
• 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.

  2003cited by this paper
• Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio.

  2003cited by this paper
• The prevalence of age-related maculopathy in iceland: Reykjavik eye study.

  2002cited by this paper
• Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study.

  2002cited by this paper
• Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

  2001cited by this paper
• Age‐specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study

  2000cited by this paper
• Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

  1998cited by this paper
• The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

  1997cited by this paper
• Prevalence of age-related maculopathy. The Beaver Dam Eye Study.

  1992cited by this paper
• The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus.

  1992cited by this paper

• The potential role of adipokines and hepatokines in age-related ocular diseases

  2025cites this paper
• Development and Validation of the Asian AMD Age-Related Macular Degeneration Risk Scale

  2025cites this paper
• Risk Stratification for Age-Related Macular Degeneration: A Cross-Sectional Study in Kazakhstan

  2025cites this paper
• Association between the weight-adjusted waist index and age-related macular degeneration: Results from NHANES 2005-2008

  2025cites this paper
• Potency Matters: The Role of Statin Intensity in Modulating Risk for Age-Related Macular Degeneration.

  2025cites this paper
• Advancements in age-related macular degeneration treatment: From traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology.

  2025cites this paper
• Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study group

  2025cites this paper
• Comparison of Neovascular Age-Related Macular Degeneration Outcomes in Established vs New Patients of a Retina Practice

  2025cites this paper
• Reducing the risk of age-related macular degeneration progression - five-year follow-up study in Ukraine and Moldova

  2025influential citation
• Oculomics: Current Concepts and Evidence.

  2025cites this paper
• Artificial intelligence-driven diagnosis for age-related macular degeneration bridging pathology and engineering: a survey

  2025influential citation
• Dissecting the biological complexity of age-related macular degeneration: Is it one disease, multiple separate diseases, or a spectrum?

  2025cites this paper
• Risk factors for wet macular degeneration: a systematic review, with novel insights from the Scottish Heart Health Extended Cohort

  2025cites this paper
• Geographic atrophy in age-related macular degeneration

  2025cites this paper
• Systematic Review of Proteomics in Age-Related Macular Degeneration and Pathway Analysis of Significant Protein Changes

  2025cites this paper
• Prevalence and Risk Factors of Age-Related Macular Degeneration in South Korea: Korea National Health and Nutrition Examination Survey

  2024cites this paper
• Phenibut—an Illegal Food Supplement With Psychotropic Effects and Health Risks.

  2024cites this paper
• Blue light-induced phototoxicity in retinal cells: implications in age-related macular degeneration

  2024cites this paper
• Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies

  2024cites this paper
• Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration

  2024cites this paper
• Retinal Pigment Epithelium Curvature Can Predict Late Age-Related Macular Degeneration

  2024influential citation
• Macular neovascularization.

  2024cites this paper
• Immunogenetic and Environmental Factors in Age-Related Macular Disease

  2024cites this paper
• Comparative quantitative analysis of optical coherence tomography angiography in varied morphologies of macular neovascularization following intravitreal conbercept and ranibizumab treatments for neovascular age‑related macular degeneration

  2024cites this paper
• Recent Advances in Our Understanding of Age-Related Macular Degeneration: Mitochondrial Dysfunction, Redox Signaling, and the Complement System

  2024cites this paper
• Short exposure to photo-oxidative damage triggers molecular signals indicative of early retinal degeneration

  2023cites this paper
• Age-Related Macular Degeneration Prevalence and its Risk Factors in Iran: A Systematic Review and Meta-Analysis Study

  2023cites this paper
• An overview of retinal light damage models for preclinical studies on age-related macular degeneration: identifying molecular hallmarks and therapeutic targets

  2023cites this paper
• Shedding light on eye disease in obesity: A review

  2023cites this paper
• Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining

  2023cites this paper
• Systemic Dyslipidemia in Age-related Macular Degeneration

  2023cites this paper
• The Emerging Role of Gut Microbiota in Age-related Macular Degeneration.

  2023cites this paper
• Prevalence and Associated Risk Factors of Age-Related Macular Degeneration in the Retina Clinic at a Tertiary Center in Makkah Province, Saudi Arabia: A Retrospective Record Review

  2023cites this paper
• Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration

  2022cites this paper
• A genome-wide association study of serum proteins reveals shared loci with common diseases

  2022cites this paper
• The Need for Artificial Intelligence Based Risk Factor Analysis for Age-Related Macular Degeneration: A Review

  2022cites this paper
• The effect of a chrysanthemum water extract in protecting the retina of mice from light damage

  2022cites this paper
• Artificial Intelligence Analysis of Biofluid Markers in Age-Related Macular Degeneration: A Systematic Review

  2022cites this paper
• The Role of Medical Image Modalities and AI in the Early Detection, Diagnosis and Grading of Retinal Diseases: A Survey

  2022cites this paper
• Dust Storms Increase the Risk of Age-Related Macular Degeneration

  2022cites this paper
• Sex and Age-Related Differences in Complement Factors Among Patients With Intermediate Age-Related Macular Degeneration

  2022cites this paper
• Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration—Neurodegenerative Disease

  2022cites this paper
• Tilapia nilotica Head Lipids Improved Bone Loss by Regulating Inflammation and Serum Metabolism Through Gut Microbiota in Ovariectomized Rats

  2022cites this paper
• Association of Systemic Inflammatory Factors with Progression to Advanced Age-related Macular Degeneration

  2021cites this paper
• AICAR upregulates ABCA1/ABCG1 expression in the retinal pigment epithelium and reduces Bruch's membrane lipid deposit in ApoE deficient mice.

  2021cites this paper
• Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration

  2021cites this paper
• Efficacy of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular Degeneration and Systemic Cardiovascular Risk Factors

  2021cites this paper
• Global Incidence, Progression, and Risk Factors of Age-Related Macular Degeneration and Projection of Disease Statistics in 30 Years: A Modeling Study

  2021cites this paper
• Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models

  2021cites this paper
• The Role of Oxidative Stress and the Importance of miRNAs as Potential Biomarkers in the Development of Age-Related Macular Degeneration

  2021cites this paper
• A proteogenomic signature of age-related macular degeneration in blood

  2021cites this paper
• A genome-wide association study of serum proteins reveals shared loci with common diseases

  2021cites this paper
• Obesity and risk of age-related eye diseases: a systematic review of prospective population-based studies

  2021cites this paper
• Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen

  2021cites this paper
• Epidemiology and Risk Factors in Age-Related Macular Degeneration (AMD)

  2020cites this paper
• Risk factors for progression of age‐related macular degeneration

  2020influential citation
• Major Predictive Factors for Progression of Early to Late Age-Related Macular Degeneration

  2020cites this paper
• Evaluation of different macular degenerations Function, morphology and clinical outcomes

  2020cites this paper
• High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases

  2020cites this paper
• Geographic distributions of age-related macular degeneration incidence: a systematic review and meta-analysis

  2020cites this paper
• Oxidative Stress as a Therapeutic Target for the Prevention and Treatment of Early Age-related Macular Degeneration.

  2020cites this paper
• Ten-year Progression from Intermediate to Exudative Age-related Macular Degeneration and Risk Factors-Bundang AMD Cohort Study Report 1.

  2020cites this paper
• Молекулярные механизмы формирования друз в сетчатке глаза при возрастной макулярной дегенерации. Обзор

  2020cites this paper
• The anti-oxidative Effect of Chrysanthemum Extract on Retinal- light Damage of Mice

  2020cites this paper
• Molecular Mechanisms of Druze Formation in the Retina in Age-Related Macular Degeneration

  2020cites this paper
• Body size at birth and age‐related macular degeneration in old age

  2019cites this paper
• EYES WITH SUBRETINAL DRUSENOID DEPOSITS AND NO DRUSEN: Progression of Macular Findings

  2019cites this paper
• [Molecular and genetic aspects of age-related macular degeneration and glaucoma].

  2019cites this paper
• Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration

  2019cites this paper
• The Role of Imaging in Age-Related Macular Degeneration

  2019cites this paper
• Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration

  2019cites this paper
• Light-induced Nrf2−/− mice as atrophic age-related macular degeneration model and treatment with nanoceria laden injectable hydrogel

  2019cites this paper
• Novel anti-angiogenic PEDF-Derived small peptides mitigate, choroidal neovascularization.

  2019cites this paper
• The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration

  2019cites this paper
• Antecedents of Soft Drusen, the Specific Deposits of Age-Related Macular Degeneration, in the Biology of Human Macula

  2018cites this paper
• Changing vision: a review of pharmacogenetic studies for treatment response in age-related macular degeneration patients.

  2018cites this paper
• Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration.

  2018cites this paper
• Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging

  2018cites this paper
• Review of the association between retinal microvascular characteristics and eye disease

  2018cites this paper
• Orthostatic hypertension as a risk factor for age‐related macular degeneration: Evidence from the Irish longitudinal study on ageing

  2018cites this paper
• Pharmaceutical Induction of PGC-1α Promotes Retinal Pigment Epithelial Cell Metabolism and Protects against Oxidative Damage

  2018cites this paper
• Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration.

  2017cites this paper
• [Multifocal electroretinography for therapeutic effect evaluation of intravitreal injection Lucentis for wet age-related macular degeneration].

  2017cites this paper
• Effects of white light‐emitting diode (LED) exposure on retinal pigment epithelium in vivo

  2017cites this paper
• HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization

  2017cites this paper
• Mitochondrial dysfunction in ocular disease: Focus on glaucoma.

  2017cites this paper
• Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration

  2017cites this paper
• Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.

  2017cites this paper
• Overweight, Obesity, and Risk of Age-Related Macular Degeneration.

  2016cites this paper
• Statistical and experimental analysis of genetic and non-genetic markers associated with risk and progression of age-related macular degeneration (AMD)

  2016cites this paper
• Improving reading performance in peripheral vision: An adaptive training method

  2016cites this paper
• Association of lipids with age-related macular degeneration.

  2016cites this paper
• Epidemiologie der altersbedingten Makuladegeneration

  2016cites this paper
• The evidence informing the surgeon's selection of intraocular lens on the basis of light transmittance properties

  2016cites this paper
• Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.

  2016cites this paper
• The Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration

  2016cites this paper
• High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration

  2016cites this paper
• Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism

  2016influential citation
• Frequency, Phenotypic Characteristics and Progression of Atrophy Associated With a Diseased Bruch's Membrane in Pseudoxanthoma Elasticum.

  2016cites this paper
• Associations Between the T280M and V249I SNPs in CX3CR1 and the Risk of Age-Related Macular Degeneration.

  2015cites this paper